Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin vs Hyaluronic Acid in Stage III Periodontitis
NCT07746206Phase 1Recruiting
- Sponsor
- Doaa Atta Aid
- Start
- Jul 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Generex Oral-lyn and hyaluronic acid sodium composite gel for injection in periodontitis (3 arms), sponsored by Doaa Atta Aid. Primary endpoints: Periodontal Pocket Depth at 6 months and Clinical Attachment Loss at 6 months. Started Jul 2026; status: recruiting.
02
Drugs
Generex Oral-lynhyaluronic acid sodium composite gel for injection
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07746206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746206.